153 related articles for article (PubMed ID: 36529819)
1. Two unrelated cases with biallelic CHEK2 variants:a novel condition with constitutional chromosomal instability?
Bottillo I; Savino E; Majore S; Mulargia C; Valiante M; Ferraris A; Rossi V; Svegliati F; Ciccone MP; Brusco F; Grammatico B; Di Giacomo G; Bargiacchi S; D'Angelantonio D; Grammatico P
Eur J Hum Genet; 2023 Apr; 31(4):474-478. PubMed ID: 36529819
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of CHEK2 p.(Asp438Tyr) allele in inherited breast cancer predisposition.
Kumpula TA; Koivuluoma S; Soikkonen L; Vorimo S; Moilanen J; Winqvist R; Mantere T; Kuismin O; Pylkäs K
Fam Cancer; 2023 Jul; 22(3):291-294. PubMed ID: 36653541
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.
Pavlovica K; Irmejs A; Noukas M; Palover M; Kals M; Tonisson N; Metspalu A; Gronwald J; Lubinski J; Murmane D; Kalnina A; Loza P; Maksimenko J; Trofimovics G; Subatniece S; Daneberga Z; Miklasevics E; Gardovskis J
Eur J Med Genet; 2022 May; 65(5):104477. PubMed ID: 35314380
[TBL] [Abstract][Full Text] [Related]
4. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
Bell DW; Kim SH; Godwin AK; Schiripo TA; Harris PL; Haserlat SM; Wahrer DC; Haiman CA; Daly MB; Niendorf KB; Smith MR; Sgroi DC; Garber JE; Olopade OI; Le Marchand L; Henderson BE; Altshuler D; Haber DA; Freedman ML
Int J Cancer; 2007 Dec; 121(12):2661-7. PubMed ID: 17721994
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal radiosensitivity of breast cancer with a CHEK2 mutation.
Baeyens A; Claes K; Willems P; De Ruyck K; Thierens H; Vral A
Cancer Genet Cytogenet; 2005 Dec; 163(2):106-12. PubMed ID: 16337852
[TBL] [Abstract][Full Text] [Related]
6. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
7. CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.
Adank MA; Jonker MA; Kluijt I; van Mil SE; Oldenburg RA; Mooi WJ; Hogervorst FB; van den Ouweland AM; Gille JJ; Schmidt MK; van der Vaart AW; Meijers-Heijboer H; Waisfisz Q
J Med Genet; 2011 Dec; 48(12):860-3. PubMed ID: 22058428
[TBL] [Abstract][Full Text] [Related]
8. A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients.
Wendt C; Muranen TA; Mielikäinen L; Thutkawkorapin J; Blomqvist C; Jiao X; Ehrencrona H; Tham E; Arver B; Melin B; Kuchinskaya E; Stenmark Askmalm M; Paulsson-Karlsson Y; Einbeigi Z; von Wachenfeldt Väppling A; Kalso E; Tasmuth T; Kallioniemi A; Aittomäki K; Nevanlinna H; Borg Å; Lindblom A
Sci Rep; 2021 Jul; 11(1):14763. PubMed ID: 34285278
[TBL] [Abstract][Full Text] [Related]
9. [CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer].
Adank MA; Hes FJ; van Zelst-Stams WA; van den Tol MP; Seynaeve C; Oosterwijk JC
Ned Tijdschr Geneeskd; 2015; 159():A8910. PubMed ID: 26332814
[TBL] [Abstract][Full Text] [Related]
10. Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.
Janiszewska H; Bąk A; Skonieczka K; Jaśkowiec A; Kiełbiński M; Jachalska A; Czyżewska M; Jaźwiec B; Kuliszkiewicz-Janus M; Czyż J; Kuliczkowski K; Haus O
Leuk Res; 2018 Jul; 70():74-78. PubMed ID: 29902706
[TBL] [Abstract][Full Text] [Related]
11. CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Abud J; Koehler-Santos P; Ashton-Prolla P; Prolla JC;
Arq Gastroenterol; 2012 Dec; 49(4):273-8. PubMed ID: 23329222
[TBL] [Abstract][Full Text] [Related]
12. Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotype.
Paperna T; Sharon-Shwartzman N; Kurolap A; Goldberg Y; Moustafa N; Carasso Y; Feinstien M; Mory A; Reznick-Levi G; Gonzaga-Jauregui C; Shuldiner AR; Basel-Salmon L; Ofran Y; Half EE; Baris Feldman H
J Med Genet; 2020 Jul; 57(7):500-504. PubMed ID: 30858171
[TBL] [Abstract][Full Text] [Related]
13. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.
Massink MP; Kooi IE; Martens JW; Waisfisz Q; Meijers-Heijboer H
BMC Cancer; 2015 Nov; 15():877. PubMed ID: 26553136
[TBL] [Abstract][Full Text] [Related]
15. The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Oldenburg RA; Kroeze-Jansema K; Kraan J; Morreau H; Klijn JG; Hoogerbrugge N; Ligtenberg MJ; van Asperen CJ; Vasen HF; Meijers C; Meijers-Heijboer H; de Bock TH; Cornelisse CJ; Devilee P
Cancer Res; 2003 Dec; 63(23):8153-7. PubMed ID: 14678969
[TBL] [Abstract][Full Text] [Related]
16. [CHEK2 c.1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):443-5. PubMed ID: 16883537
[TBL] [Abstract][Full Text] [Related]
17. CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases.
Apostolou P; Fostira F; Papamentzelopoulou M; Michelli M; Panopoulos C; Fountzilas G; Konstantopoulou I; Voutsinas GE; Yannoukakos D
Cancer Genet; 2015 Apr; 208(4):129-34. PubMed ID: 25835597
[TBL] [Abstract][Full Text] [Related]
18. Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias.
Bahassi el M; Robbins SB; Yin M; Boivin GP; Kuiper R; van Steeg H; Stambrook PJ
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17111-6. PubMed ID: 19805189
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel BRCA2 and CHEK2 A-C-G-C haplotype in Turkish patients affected with breast cancer.
Haytural H; Yalcinkaya N; Akan G; Arikan S; Ozkok E; Cakmakoglu B; Yaylim I; Aydin M; Atalar F
Asian Pac J Cancer Prev; 2013; 14(5):3229-35. PubMed ID: 23803109
[TBL] [Abstract][Full Text] [Related]
20. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
CHEK2 Breast Cancer Case-Control Consortium
Am J Hum Genet; 2004 Jun; 74(6):1175-82. PubMed ID: 15122511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
